{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:47:55Z","timestamp":1793789275491,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41593-018-0296-9","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T05:53:38Z","timestamp":1546235618000},"page":"191-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":531,"title":["Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5807-190X","authenticated-orcid":false,"given":"Samira","family":"Parhizkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Arzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Kleinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Deussing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Focke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Nuscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-1814","authenticated-orcid":false,"given":"Monica","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ghasemigharagoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Katzmarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Krasemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan F.","family":"Lichtenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Sebastian","family":"Monasor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4403-9559","authenticated-orcid":false,"given":"Sabina","family":"Tahirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Willem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Pettkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Butovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7186-4653","authenticated-orcid":false,"given":"Dieter","family":"Edbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-5100","authenticated-orcid":false,"given":"Ali","family":"Ert\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A.","family":"Grathwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1346-8924","authenticated-orcid":false,"given":"Jonas J.","family":"Neher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-2220","authenticated-orcid":false,"given":"Melanie","family":"Meyer-Luehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-1627","authenticated-orcid":false,"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"296_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45\u201351 (2013).","journal-title":"Nature"},{"key":"296_CR2","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann, M. et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781\u20131784 (2006).","journal-title":"Science"},{"key":"296_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky, O. & Weiner, H. L. Microglial signatures and their role in health and disease. Nat. Rev. Neurosci. 19, 622\u2013635 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"296_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","volume":"19","author":"WM Song","year":"2018","unstructured":"Song, W. M. & Colonna, M. The identity and function of microglia in neurodegeneration. Nat. Immunol. 19, 1048\u20131058 (2018).","journal-title":"Nat. Immunol."},{"key":"296_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich, J. D., Ulland, T. K., Colonna, M. & Holtzman, D. M. Elucidating the role of TREM2 in Alzheimer\u2019s disease. Neuron 94, 237\u2013248 (2017).","journal-title":"Neuron"},{"key":"296_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease. N. Engl. J. Med. 368, 117\u2013127 (2013).","journal-title":"N. Engl. J. Med."},{"key":"296_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"296_CR8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.15252\/embr.201743922","volume":"18","author":"F Mazaheri","year":"2017","unstructured":"Mazaheri, F. et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 18, 1186\u20131198 (2017).","journal-title":"EMBO Rep."},{"key":"296_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170, 649\u2013663.e13 (2017).","journal-title":"Cell"},{"key":"296_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.15252\/embj.201796516","volume":"36","author":"G Kleinberger","year":"2017","unstructured":"Kleinberger, G. et al. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. EMBO J. 36, 1837\u20131853 (2017).","journal-title":"EMBO J."},{"key":"296_CR11","doi-asserted-by":"publisher","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger, G. et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci. Transl. Med. 6, 243ra86 (2014).","journal-title":"Sci. Transl. Med."},{"key":"296_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky, O. et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131\u2013143 (2014).","journal-title":"Nat. Neurosci."},{"key":"296_CR13","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"296_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"296_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu, C. C. et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron 96, 1024\u20131032.e3 (2017).","journal-title":"Neuron"},{"key":"296_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"TV Huynh","year":"2017","unstructured":"Huynh, T. V. et al. Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron 96, 1013\u20131023.e4 (2017).","journal-title":"Neuron"},{"key":"296_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/372092a0","volume":"372","author":"J Ma","year":"1994","unstructured":"Ma, J., Yee, A., Brewer, H. B. Jr, Das, S. & Potter, H. Amyloid-associated proteins \u03b11-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer \u03b2-protein into filaments. Nature 372, 92\u201394 (1994).","journal-title":"Nature"},{"key":"296_CR18","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao, F. et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J. Clin. Invest. 128, 2144\u20132155 (2018).","journal-title":"J. Clin. Invest."},{"key":"296_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"TR Jay","year":"2017","unstructured":"Jay, T. R. et al. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease. J. Neurosci. 37, 637\u2013647 (2017).","journal-title":"J. Neurosci."},{"key":"296_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"296_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay, T. R. et al. TREM2 deficiency eliminates TREM2+inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models. J. Exp. Med. 212, 287\u2013295 (2015).","journal-title":"J. Exp. Med."},{"key":"296_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160, 1061\u20131071 (2015).","journal-title":"Cell"},{"key":"296_CR23","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","volume":"20","author":"MD Kane","year":"2000","unstructured":"Kane, M. D. et al. Evidence for seeding of \u03b2-amyloid by intracerebral infusion of Alzheimer brain extracts in \u03b2-amyloid precursor protein-transgenic mice. J. Neurosci. 20, 3606\u20133611 (2000).","journal-title":"J. Neurosci."},{"key":"296_CR24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde, R. et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 7, 940\u2013946 (2006).","journal-title":"EMBO Rep."},{"key":"296_CR25","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","volume":"177","author":"IR Turnbull","year":"2006","unstructured":"Turnbull, I. R. et al. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520\u20133524 (2006).","journal-title":"J. Immunol."},{"key":"296_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","volume":"70","author":"RJ Guerreiro","year":"2013","unstructured":"Guerreiro, R. J. et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 70, 78\u201384 (2013).","journal-title":"JAMA Neurol."},{"key":"296_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich, J. D. et al. Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2. Mol. Neurodegener. 9, 20 (2014).","journal-title":"Mol. Neurodegener."},{"key":"296_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnagi.2017.00008","volume":"9","author":"M Brendel","year":"2017","unstructured":"Brendel, M. et al. Increase of TREM2 during aging of an Alzheimer\u2019s disease mouse model is paralleled by microglial activation and amyloidosis. Front. Aging Neurosci. 9, 8 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"296_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2967\/jnumed.113.125625","volume":"55","author":"AM Dickens","year":"2014","unstructured":"Dickens, A. M. et al. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J. Nucl. Med. 55, 466\u2013472 (2014).","journal-title":"J. Nucl. Med."},{"key":"296_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","volume":"3","author":"IR Holtman","year":"2015","unstructured":"Holtman, I. R. et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol. Commun. 3, 31 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"296_CR31","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn.2432","volume":"12","author":"SA Grathwohl","year":"2009","unstructured":"Grathwohl, S. A. et al. Formation and maintenance of Alzheimer\u2019s disease \u03b2-amyloid plaques in the absence of microglia. Nat. Neurosci. 12, 1361\u20131363 (2009).","journal-title":"Nat. Neurosci."},{"key":"296_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm1177","volume":"11","author":"FL Heppner","year":"2005","unstructured":"Heppner, F. L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146\u2013152 (2005).","journal-title":"Nat. Med."},{"key":"296_CR33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat. Genet. 49, 1373\u20131384 (2017).","journal-title":"Nat. Genet."},{"key":"296_CR34","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich, J. D. et al. ApoE facilitates the microglial response to amyloid plaque pathology. J. Exp. Med. 215, 1047\u20131058 (2018).","journal-title":"J. Exp. Med."},{"key":"296_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","volume":"13","author":"PJ Cheng-Hathaway","year":"2018","unstructured":"Cheng-Hathaway, P. J. et al. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease. Mol. Neurodegener. 13, 29 (2018).","journal-title":"Mol. Neurodegener."},{"key":"296_CR36","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","volume":"32","author":"S Lavisse","year":"2012","unstructured":"Lavisse, S. et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J. Neurosci. 32, 10809\u201310818 (2012).","journal-title":"J. Neurosci."},{"key":"296_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.nucmedbio.2015.05.004","volume":"42","author":"WF Chau","year":"2015","unstructured":"Chau, W. F. et al. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [18F]GE-180. Nucl. Med. Biol. 42, 711\u2013719 (2015).","journal-title":"Nucl. Med. Biol."},{"key":"296_CR38","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00259-016-3444-z","volume":"43","author":"C Feeney","year":"2016","unstructured":"Feeney, C. et al. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. Eur. J. Nucl. Med. Mol. Imaging 43, 2201\u20132210 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"296_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-017-0340-x","volume":"7","author":"L Vomacka","year":"2017","unstructured":"Vomacka, L. et al. TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis. EJNMMI Res. 7, 89 (2017).","journal-title":"EJNMMI Res."},{"key":"296_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00259-014-2939-8","volume":"42","author":"H Boutin","year":"2015","unstructured":"Boutin, H. et al. 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. Eur. J. Nucl. Med. Mol. Imaging 42, 503\u2013511 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"296_CR41","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.7150\/thno.17666","volume":"7","author":"ML James","year":"2017","unstructured":"James, M. L. et al. [18F]GE-180 PET detects reduced microglia activation after LM11A-31 therapy in a mouse model of Alzheimer\u2019s disease. Theranostics 7, 1422\u20131436 (2017).","journal-title":"Theranostics"},{"key":"296_CR42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"296_CR43","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"296_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37\u201353 (2016).","journal-title":"Neuron"},{"key":"296_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan, A. M. et al. Human and murine ApoE markedly alters A\u03b2 metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 9, 305\u2013318 (2002).","journal-title":"Neurobiol. Dis."},{"key":"296_CR46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","volume":"84","author":"R Sperling","year":"2014","unstructured":"Sperling, R., Mormino, E. & Johnson, K. The evolution of preclinical Alzheimer\u2019s disease: implications for prevention trials. Neuron 84, 608\u2013622 (2014).","journal-title":"Neuron"},{"key":"296_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.15252\/embj.201797021","volume":"37","author":"S Ziegler-Waldkirch","year":"2018","unstructured":"Ziegler-Waldkirch, S. et al. Seed-induced A\u03b2 deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer\u2019s disease. EMBO J. 37, 167\u2013182 (2018).","journal-title":"EMBO J."},{"key":"296_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.20171529","volume":"215","author":"WM Song","year":"2018","unstructured":"Song, W. M. et al. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J. Exp. Med. 215, 745\u2013760 (2018).","journal-title":"J. Exp. Med."},{"key":"296_CR49","doi-asserted-by":"publisher","first-page":"369ra178","DOI":"10.1126\/scitranslmed.aag1767","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet, M. et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury. Sci. Transl. Med. 8, 369ra178 (2016).","journal-title":"Sci. Transl. Med."},{"key":"296_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356 (2016).","journal-title":"Nature"},{"key":"296_CR51","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/002215540004800906","volume":"48","author":"SD Styren","year":"2000","unstructured":"Styren, S. D., Hamilton, R. L., Styren, G. C. & Klunk, W. E. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer\u2019s disease pathology. J. Histochem. Cytochem. 48, 1223\u20131232 (2000).","journal-title":"J. Histochem. Cytochem."},{"key":"296_CR52","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2967\/jnumed.115.167858","volume":"57","author":"M Brendel","year":"2016","unstructured":"Brendel, M. et al. Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study. J. Nucl. Med. 57, 954\u2013960 (2016).","journal-title":"J. Nucl. Med."},{"key":"296_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnins.2016.00045","volume":"10","author":"F Overhoff","year":"2016","unstructured":"Overhoff, F. et al. Automated spatial brain normalization and hindbrain white matter reference tissue give improved [18F]-florbetaben PET quantitation in Alzheimer\u2019s model mice. Front. Neurosci. 10, 45 (2016).","journal-title":"Front. Neurosci."},{"key":"296_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuroimage.2017.10.006","volume":"165","author":"M Deussing","year":"2018","unstructured":"Deussing, M. et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F]GE180 PET quantification. Neuroimage 165, 83\u201391 (2018).","journal-title":"Neuroimage"},{"key":"296_CR55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1074\/jbc.M708754200","volume":"283","author":"RM Page","year":"2008","unstructured":"Page, R. M. et al. Generation of A\u03b238 and A\u03b242 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and \u03b3-secretase modulation. J. Biol. Chem. 283, 677\u2013683 (2008).","journal-title":"J. Biol. Chem."},{"key":"296_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.15252\/embj.201694591","volume":"36","author":"A Daria","year":"2017","unstructured":"Daria, A. et al. Young microglia restore amyloid plaque clearance of aged microglia. EMBO J. 36, 583\u2013603 (2017).","journal-title":"EMBO J."},{"key":"296_CR57","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362 (2009).","journal-title":"Nat. Methods"},{"key":"296_CR58","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"296_CR59","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/pmic.201500488","volume":"16","author":"R Bruderer","year":"2016","unstructured":"Bruderer, R., Bernhardt, O. M., Gandhi, T. & Reiter, L. High-precision iRT prediction in the targeted analysis of data-independent acquisition and its impact on identification and quantitation. Proteomics 16, 2246\u20132256 (2016).","journal-title":"Proteomics"},{"key":"296_CR60","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell. Proteomics"}],"updated-by":[{"DOI":"10.1038\/s41593-024-01752-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000}}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0296-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0296-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0296-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T03:04:44Z","timestamp":1724123084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0296-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1038\/s41593-018-0296-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734770147.793555968","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"19 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41593-024-01752-x","URL":"https:\/\/doi.org\/10.1038\/s41593-024-01752-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.H. collaborates with Denali and received a speaker honorarium of Roche and Novartis. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H. consults for Denali, Eli Lilly, Glaxosmithkline, and AbbVie. A.R. received consultant and speaker honoria from Piramal Imaging and GE Healthcare. O.B. collaborates with Sanofi. S.T. collaborates with Ono Pharmaceuticals (Japan). S.A.G is an employee of Neurimmune AG. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}